Below are the financial statements of Bio Rad Laboratories, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net sales | 2,566.5a | 2,671.2a | 2,802.2a |
| Cost of goods sold | -1,187.6a | -1,244.3a | -1,234.9a |
| Gross profit | 1,378.9a | 1,426.9a | 1,567.3a |
| Selling, general and administrative expense | -814a | -841.7a | -827.8a |
| Research and development expense | -295.9a | -247.4a | -256.9a |
| Income from operations | 269a | 337.8a | 482.6a |
| Interest expense | -48.9a | -49.4a | -38.1a |
| Foreign currency exchange gains, net | -3.9a | -7.3a | -0.2a |
| Losses from change in fair market value of equity securities and loan receivable | -2,656.8a | -1,252.3a | -5,193.6a |
| Other income, net | -90.3a | -106.5a | -44.7a |
| Net loss before income taxes | -2,342.5a | -850.1a | -4,704.2a |
| Benefit from income taxes | 498.3a | 212.8a | 1,076.7a |
| Net loss | -1,844.2a | -637.3a | -3,627.5a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Bio Rad Laboratories’s data sources below and access millions more through our Disclosure Search.